Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis
Clinical trial NCT03831776 · COMPLETED
Trial details
- NCT number
- NCT03831776
- Sponsor
- St. Olavs Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2024-12-31
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.